Pegylated (40kDa) interferon alfa-2a (PEGASYS®) in combination with ribavirin: Efficacy and safety results from a phase III, randomized, actively-controlled, multicenter study
- 1 April 2001
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 120 (5) , A55
- https://doi.org/10.1016/s0016-5085(01)80271-7
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: